SABS

insider transactions

SAB Biotherapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·F
Mar 24, 26

Alexandra Kropotova

CHIEF MEDICAL OFFICER

—

988 sh

Own -2%
Grant·A
Feb 3, 26

Eddie Joe Sullivan KEY

PRESIDENT

$0

3.0M sh

Own New
Grant·A
Feb 3, 26

Lucy To KEY

Chief Financial Officer

$0

2.4M sh

Own New
Grant·A
Feb 3, 26

Samuel J Reich KEY

CEO

$0

4.8M sh

Own New
Grant·A
Feb 3, 26

Alexandra Kropotova

CHIEF MEDICAL OFFICER

$0

2.4M sh

Own New
Grant·A
Feb 3, 26

Christoph Lawrence Bausch

CHIEF OPERATING OFFICER

$0

1.8M sh

Own New
Grant·A
Jan 5, 26

David Zaccardelli

Director

$0

240.0K sh

Own New
Grant·A
Jan 5, 26

Rita Jain

Director

$0

240.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Mar 24, 2026	Alexandra Kropotova	CHIEF MEDICAL OFFICER	Other F	988	-2%	—	—
Feb 3, 2026	Eddie Joe Sullivan KEY	PRESIDENT	Grant A	3.0M	New	—	$0
Feb 3, 2026	Lucy To KEY	Chief Financial Officer	Grant A	2.4M	New	—	$0
Feb 3, 2026	Samuel J Reich KEY	CEO	Grant A	4.8M	New	—	$0
Feb 3, 2026	Alexandra Kropotova	CHIEF MEDICAL OFFICER	Grant A	2.4M	New	—	$0
Feb 3, 2026	Christoph Lawrence Bausch	CHIEF OPERATING OFFICER	Grant A	1.8M	New	—	$0
Jan 5, 2026	David Zaccardelli	Director	Grant A	240.0K	New	—	$0
Jan 5, 2026	Rita Jain	Director	Grant A	240.0K	New	—	$0

About SABS insider trading

This page tracks insider transactions for SAB Biotherapeutics, Inc. (SABS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.